{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:24:31Z","timestamp":1791321871778,"version":"4.3.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T00:00:00Z","timestamp":1348444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T00:00:00Z","timestamp":1348444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1038\/bmt.2012.187","type":"journal-article","created":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T11:06:48Z","timestamp":1348484808000},"page":"587-592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":102,"title":["Risk and prognostic factors for acute GVHD based on NIH consensus criteria"],"prefix":"10.1038","volume":"48","author":[{"given":"S-E","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B-S","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-H","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-H","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-H","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-A","family":"Yahng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K-S","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-J","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-J","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-K","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-G","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D-W","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-W","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W-S","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-W","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,24]]},"reference":[{"key":"BFbmt2012187_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2141.1987.tb06160.x","volume":"67","author":"RP Gale","year":"1987","unstructured":"Gale RP, Bortin MM, van Bekkum DW, Biggs JC, Dicke KA, Gluckman E et al. Risk factors for acute graft-versus-host disease. Br J Haematol 1987; 67: 397\u2013406.","journal-title":"Br J Haematol"},{"key":"BFbmt2012187_CR2","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1097\/00007890-199106000-00010","volume":"51","author":"D Weisdorf","year":"1991","unstructured":"Weisdorf D, Hakke R, Blazar B, Miller W, McGlave P, Ramsay N et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 1991; 51: 1197\u20131203.","journal-title":"Transplantation"},{"key":"BFbmt2012187_CR3","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V80.7.1838.1838","volume":"80","author":"RA Nash","year":"1992","unstructured":"Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992; 80: 1838\u20131845.","journal-title":"Blood"},{"key":"BFbmt2012187_CR4","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","volume":"98","author":"C Kollman","year":"2001","unstructured":"Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001; 98: 2043\u20132051.","journal-title":"Blood"},{"key":"BFbmt2012187_CR5","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","volume":"110","author":"SJ Lee","year":"2007","unstructured":"Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576\u20134583.","journal-title":"Blood"},{"key":"BFbmt2012187_CR6","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.bbmt.2007.08.006","volume":"13","author":"M Eapen","year":"2007","unstructured":"Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant 2007; 13: 1461\u20131468.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012187_CR7","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1200\/JCO.2008.17.6545","volume":"26","author":"T Hahn","year":"2008","unstructured":"Hahn T, McCarthy PL, Zhang MJ, Wang D, Arora M, Frangoul H et al. Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol 2008; 26: 5728\u20135734.","journal-title":"J Clin Oncol"},{"key":"BFbmt2012187_CR8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945\u2013956.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012187_CR9","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","volume":"117","author":"ME Flowers","year":"2011","unstructured":"Flowers ME, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011; 117: 3214\u20133219.","journal-title":"Blood"},{"key":"BFbmt2012187_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/sj.bmt.1705410","volume":"38","author":"CK Min","year":"2006","unstructured":"Min CK, Kim SY, Lee MJ, Eom KS, Kim YJ, Kim HJ et al. Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation. Bone marrow transplant 2006; 38: 149\u2013156.","journal-title":"Bone marrow transplant"},{"key":"BFbmt2012187_CR11","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.bbmt.2012.01.010","volume":"18","author":"BS Cho","year":"2012","unstructured":"Cho BS, Lee SE, Song HH, Lee JH, Yahng SA, Eom KS et al. Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health Consensus Criteria and Associated Outcomes. Biol Blood Marrow Transplant 2012; 18: 1136\u20131143.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012187_CR12","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on acute GVHD grading. Bone marrow transplant 1995; 15: 825\u2013828.","journal-title":"Bone marrow transplant"},{"key":"BFbmt2012187_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","volume":"9","author":"SJ Lee","year":"2003","unstructured":"Lee SJ, Vogelsang G, Flowers ME . Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215\u2013233.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012187_CR14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/sj.bmt.1705976","volume":"41","author":"BS Cho","year":"2008","unstructured":"Cho BS, Min CK, Eom KS, Kim YJ, Kim HJ, Lee S et al. Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone marrow transplant 2008; 41: 813\u2013820.","journal-title":"Bone marrow transplant"},{"key":"BFbmt2012187_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/leu.2008.276","volume":"23","author":"BS Cho","year":"2009","unstructured":"Cho BS, Min CK, Eom KS, Kim YJ, Kim HJ, Lee S et al. Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia 2009; 23: 78\u201384.","journal-title":"Leukemia"},{"key":"BFbmt2012187_CR16","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.bbmt.2008.04.003","volume":"14","author":"D Weisdorf","year":"2008","unstructured":"Weisdorf D, Spellman S, Haagenson M, Horowitz M, Lee S, Anasetti C et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant 2008; 14: 748\u2013758.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012187_CR17","first-page":"663","volume":"15","author":"MD Eisner","year":"1995","unstructured":"Eisner MD, August CS . Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation. Bone marrow transplant 1995; 15: 663\u2013668.","journal-title":"Bone marrow transplant"},{"key":"BFbmt2012187_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","volume":"119","author":"M Jagasia","year":"2012","unstructured":"Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 2012; 119: 296\u2013307.","journal-title":"Blood"},{"key":"BFbmt2012187_CR19","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood.V94.4.1465","volume":"94","author":"D Przepiorka","year":"1999","unstructured":"Przepiorka D, Smith TL, Folloder J, Khouri I, Ueno NT, Mehra R et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 1999; 94: 1465\u20131470.","journal-title":"Blood"},{"key":"BFbmt2012187_CR20","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1182\/blood.V98.10.2900","volume":"98","author":"M Korbling","year":"2001","unstructured":"Korbling M, Anderlini P . Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood 2001; 98: 2900\u20132908.","journal-title":"Blood"},{"key":"BFbmt2012187_CR21","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1200\/JCO.2001.19.16.3685","volume":"19","author":"C Cutler","year":"2001","unstructured":"Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH . Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19: 3685\u20133691.","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2012187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012187","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T15:10:12Z","timestamp":1648048212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2012187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,24]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["BFbmt2012187"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2012.187","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,24]]},"assertion":[{"value":"23 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}